Our observation linking FAK and TP53 status is particularly impactful in that we identified FAK as a highly significant target for sensitization to both radiation and platinum-based chemotherapy in mutant TP53 HPV-negative HNSCC using an in vivo shRNA screen.
← all excerpts
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner.
1
—
—